FDA Import Refusal AEK-2016879-4/20003/1 — ZYDLIS HEALTH CARE LTD
The FDA refused shipment AEK-2016879-4/20003/1 from ZYDLIS HEALTH CARE LTD (India) on Sep 3, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75